29, 1-st Brestskaya Street,

Business-center "Capital Tower", level 8

Moscow, Russia, 125047 

+7 495 545-39-12

Создано с помощью инструментов Яндекс.Карт

Media Center

  • 22 February 2018

    Korea pools patient data to enable digital health schemes

    South Korea is consolidating hospital medical data into a single 10 million-patient repository. The goal is to use Korea’s established medical IT system to build a resource that supports digital health initiatives and the development of new drugs and devices.

  • 21 February 2018

    Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst

    Pfizer hasn't gained much market share with Inflectra, its biosimilar of Johnson & Johnson's Remicade, since its U.S. launch back in 2016. The company's CEO Ian Read recently said Inflectra is picking up increased commercial coverage, but an analyst figures the biosimilar's challenges aren't likely to let up this year. 

  • 20 February 2018

    Using stem cells to generate an immune attack against cancer

    Induced pluripotent stem cells (iPSCs) have the power to transform into any cell in the body, making them a prime candidate for regenerative medicine. But can they also teach the immune system to recognize and attack cancer?

  • 20 February 2018

    Russians develop advanced multiple myeloma drug candidate

    Hemopharm, a Russian biotech company, is developing a drug candidate that might help multiple myeloma patients. The new Hemopharm solution is expected to evolve to be such a drug. No direct competition has been reported so far in the global pharmaceutical market. The drug candidate is a humanized antibody with purportedly outstanding anti-tumor activity and low toxicity with proven in vivo efficacy.

Read more